Comparing two physiotherapy techniques for COPD patients on mechanical ventilation
Official title: Manual Hyperinflation Versus Diaphragmatic Proprioceptive Neuromuscular Facilitation on Pulmonary Functions in Mechanically Ventilated Patients
Run by Cairo University · NCT06221033 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests which of two physiotherapy techniques helps men with COPD on mechanical ventilation breathe better during their recovery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 60 Years |
| Sex | Men only |
| Enrollment | 60 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Alexandria, Aleksandria) |
| Trial ID | NCT06221033 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male patients aged 50 to 60 with moderate to severe COPD who are currently on mechanical ventilation.
✕Probably not a fit
Patients with unstable hemodynamics or recent thoracic or abdominal surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effects of manual hyperinflation and diaphragmatic proprioceptive neuromuscular facilitation on pulmonary functions in male patients with acute exacerbations of COPD who are on mechanical ventilation. Sixty patients aged 50 to 60 will be randomly assigned to three groups: one receiving manual hyperinflation, another receiving proprioceptive neuromuscular facilitation, and a control group. The study will utilize pre-post measures and a single-blinded, randomized controlled design to assess the effectiveness of these interventions on arterial blood gases and overall pulmonary function.
Why it matters
Potential benefit: If successful, this study could improve respiratory function and recovery outcomes for mechanically ventilated COPD patients.
How similar studies have gone: While similar physiotherapy approaches have been explored, this specific comparison of techniques in mechanically ventilated COPD patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients will be included in the study if they have the following criteria: 1. Sixty male mechanically ventilated patients. They will be ventilated on pressure support (PS) mode of MV with this setting (Positive end-expiratory pressure \[PEEP\]) less than 8 cm H2O, FiO2 0.4 or less, SpO2 higher than 90) due to AECOPD. 2. Their Glasgow Coma Scale score will be ranged from 13 to 15. 3. Their age between 50 and 60 years old. 4. Their BMI will be ranged from 25 to 34.9 kg/m2. 5. Moderate (GOLD 2) and severe (GOLD 3) stages of COPD according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) grading system for the severity of COPD. Exclusion Criteria: * The patients will be excluded from this study if they have one of the following criteria: Fever above 38.3 °C. Unstable hemodynamics. Thoracic or abdominal surgery that preclude the use of PNF exercises. Chest trauma such as rib fracture, flail chest and thoracic vertebra fracture or chest burns. Peripheral and central nervous system diseases. Active lung infection like tuberculosis. Active bleeding as alveolar hemorrhage, hemoptysis. Spinal cord injuries involved the phrenic nerve. Severe cardiac complications due to COPD.
Where it's running
-
Gamal Abdelnasser Hospital
Alexandria, Aleksandria, Egypt Recruiting
Study contacts
- Study coordinator: omar hesham, Bsc
- Email: ohesham1995@gmail.com
- Phone: 01116654844
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rademikibart IV for Acute Asthma and COPD Exacerbation
This study tests a one-time IV dose of rademikibart to help people with acute asthma or COPD flare-ups who need urgent care.
-
Observational registry for COPD patients in ICU
This study is looking at patients with severe COPD who are in the ICU to see how they are treated and what happens to them, in hopes of improving care for future patients.
-
Titrated versus standard oxygen for prehospital treatment of COPD exacerbations
This trial tests whether giving oxygen adjusted to keep blood oxygen (SpO₂) at 88–92% instead of using 100% oxygen during prehospital treatment of adults 40 and older with suspected COPD exacerbations lowers 30-day death.
-
Hospitalized adults with acute or chronic respiratory conditions: outcomes and recovery
This study tests how adults hospitalized with acute respiratory problems or chronic lung disease recover after discharge, and what factors predict readmission, stay length, and mortality.
-
Evaluating how high doses of prednisolone affect patients with inflammatory conditions
This study is trying to see how different doses of prednisolone affect patients with inflammatory conditions by looking at their blood levels and how their bodies process the medication.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.